Pioneering transcatheter aortic valve Implant (Inovare®) via transfemoral.

Autor: Pontes JC; Hospital Universitário, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brasil. carlosdorsa@uol.com.br, Duarte JJ, Silva AD, Dias AM, Benfatti RA, Gardenal N, Benfatti AF, Gomes JF Jr
Jazyk: English; Portuguese
Zdroj: Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular [Rev Bras Cir Cardiovasc] 2012 Jul-Sep; Vol. 27 (3), pp. 469-71.
DOI: 10.5935/1678-9741.20120078
Abstrakt: We present a patient with severe aortic valvular bioprosthesis dysfunction implanted for 11 years, presenting with acute pulmonary edema due to severe valvular insufficiency with severe systolic dysfunction (EF <30%) and comorbid conditions that amounted operative risk (STS score > 10). We carried out the transcatheter aortic valve implantation (Inovare® - Braile Biomedica), which was implemented successfully by transfemoral access and good patient outcomes.
Databáze: MEDLINE